多糖在炎症中的治疗潜力:当前的见解和未来的方向
Thananjeyan Balasubramaniyam1, Hye-Bin Ahn2, Juhee Lim3
1Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine-National Research Institute, Szaserow 128, 04-141 Warszawa, Poland; Department of Chemistry and RINS, Gyeongsang National University, Jinju, Gyeongnam 52828, South Korea.
International immunopharmacology
|October 1, 2025
概括
植物,微生物,藻类和动物多糖体对炎症性肠病和关节炎等疾病具有抗炎作用. 需要进一步的研究来优化这些天然化合物的输送和标准化方法.
科学领域:
- 免疫学和药理学
- 自然产品化学 自然产品化学
背景情况:
- 来自各种自然来源的多糖具有显著的抗炎性质.
- 这些化合物为炎症性疾病 (如炎症性肠病和关节炎) 提供潜在的治疗途径.
研究的目的:
- 审查多糖的来源,结构变化和抗炎机制.
- 评估其在临床前模型中的有效性,并确定其治疗应用的挑战和未来方向.
主要方法:
- 从体外 (如RAW264.7,THP-1细胞) 和体内 (如DSS诱导的大肠炎,原诱导关节炎) 模型中综合数据.
- 分析化学变化 (例如硫化) 和它们对生物活性的影响.
- 审查现有的关于多糖类抗炎机制的文献,包括NF-κB和MAPK通路.
主要成果:
- 在体外研究显示,50-200μg/mL的剂量依赖性减少了30-40%的促炎性细胞因子 (TNF-α,IL-1β).
- 在体内研究表明,在50-200毫克/公斤的疾病模型中,疾病活性指数下降,病原体病理有所改善.
- 硫化等化学修饰可以增强抗炎活性.
结论:
- 多糖是有前途的抗炎药物,在临床前模型中已证明有效.
- 挑战包括生物可用性,不一致的方法和可变剂量,需要标准化测试和先进的输送系统.
- 未来的研究应该集中在纳米技术,生物信息学和临床试验上,以实现多糖的治疗潜力.
相关概念视频
Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
Inflammatory Response
16.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.0K
Inflammatory Bowel Disease IV: Pharmacological Management
521
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
521
The JAK-STAT Signaling Pathway
12.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.1K
Microorganisms in Medicine and Therapeutics
982
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
982
T Cell Types and Functions
2.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.2K


